Stock Updates

Today’s Top Gainers in the Market Boston Scientific Corporation (NYSE:BSX) from Healthcare

Today’s top gainers include the company Boston Scientific Corporation (NYSE:BSX) which is in the industry Medical Appliances & Equipment, gaining -1.96% today. In the last week its performance is 2.67%, and 23.46% for the past quarter. Currently, Boston Scientific Corporation, BSX has a target price of 24.54, so today’s gain of -1.96% is a significant step towards its target price. The GAP today is therefore -0.33%.

Boston Scientific Corporation (NYSE:BSX), has a market cap of 33196.9, and is based in USA. Insider ownership is at 0.50%, and institutional ownership is 95.30%.

At the current price of 23.78, it has a dividend yield of *TBA, and its target price is 24.54. This is with a profit margin of -0.50%, and total debt/equity of 0.88. Boston Scientific Corporation (NYSE:BSX) has a P/E of *TBA, as well as a forward P/E of 19.64.

With a current EPS of -0.03, and a forecasted EPS growth for next year at 13.10%,Boston Scientific Corporation (NYSE:BSX) has had a EPS growth for the past five years at 24.00%. For the next five years EPS growth is projected to be 12.70%.

Performance for the year is 36.60%. Since its IPO date on 5/19/1992, the total performance to date is 31.56%.

Volume today for Boston Scientific Corporation (NYSE:BSX), is 4340495, while its average volume is 11439.64. Whilst the total gain today was -1.96%, it did have a day high of -2.72%.

Volatility for this week has been at 1.49%, and 1.51% for the month. The 52-week low for Boston Scientific Corporation, BSX has been 67.74%, while the 52-week-high has reached -2.72%.

Looking at its return of investments, which is 0.70%, and its return on assets is -0.20%. Boston Scientific Corporation (NYSE:BSX) has an operating margin of -0.80%. With a sales growth of 11.10% quarter over quarter. Bearing in mind that Boston Scientific Corporation, BSX is in the sector Healthcare, its long-term debt/equity is 0.84, and has a current ratio of 1.2 and 0.8 for quick ratio.

So what is the value of Boston Scientific Corporation? Well its PEG is *TBA, and the P/S is 4.33, along with a P/B of 5.08. Meanwhile it has a p/cash of 98.22.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Stephen Butters

Leave a Comment